Oxaliplatin
NDC 57277-002
Product Information
Oxaliplatin is a ANDA-approved product labeled by Sanja Pharmaceuticals Company. This medication is used to treat advanced cancer of the colon and rectum. It is supplied as a product. This product entry covers the primary NDC 57277-002 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 57277-002?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- OXALIPLATIN (UNII: 04ZR38536J)
- OXALIPLATIN (UNII: 04ZR38536J) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1736784 - oxaliplatin 50 MG Injection
- RxCUI: 1736786 - oxaliplatin 100 MG Injection
* Please review the full disclaimer at the bottom of this page.